Strategy Inc Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Strategy Inc (MSTR) shares rose 5.4% to $98.37 after quarterly results. Revenues were $122m, in line with estimates, but it reported a statutory loss of $24.45 per share versus prior profit expectations. For 2026, analysts kept revenue at $496.5m but shifted to a $0.16 per-share loss, and the consensus price target fell 15% to $258.
How this was made
The 30-second read
Why it matters
The key trading takeaway is a sentiment and valuation reset: reported statutory loss, analyst EPS outlook turning negative for 2026, and a 15% reduction in the consensus price target.
Market read
For MSTR traders, the article signals a near-term repricing risk tied to earnings expectations rather than revenue growth, with a lower consensus valuation and a wide target dispersion.
What to watch
The article does not detail the drivers of the statutory loss or whether the loss forecast is sensitive to assumptions; without that, the consensus target drop may overstate fundamental deterioration.
Background
Simply Wall St summarizes MSTR’s latest quarterly results and aggregates analyst forecasts for 2026, highlighting a shift from expected profit to expected loss.
Ticker impact
Strategy Inc reported quarterly results with statutory loss of $24.45 per share, shifting analyst outlook from profit to loss and cutting the consensus price target 15%.
Near-term downside bias as traders reprice valuation around the loss forecast and the lowered consensus target, with volatility likely until next earnings/updates clarify earnings trajectory.
The newest concrete facts are the reported statutory loss, the analyst forecast flip to a loss for 2026, and the 15% fall in consensus price target. Revenue is described as in-line, so the market focus is likely on earnings quality and cost/expense dynamics rather than top-line growth.
Market effects
Limited direct sector read-through; the piece is primarily company-specific and based on analyst forecast revisions rather than industry-wide new data.
No specific regional spillover beyond US-listed sentiment around MSTR.
No explicit global macro or cross-border catalyst beyond the company’s earnings and forecast changes.
Counterpoint
Because revenues are described as in-line with estimates, the loss may be driven by non-recurring items or accounting effects; traders could fade the valuation reset if earnings normalization is plausible.
Key entities
- companyStrategy Inc
NASDAQ-listed issuer whose quarterly results and subsequent analyst forecast revisions are discussed.
- market participantsAnalysts (ten-analyst consensus)
Forecasts for 2026 revenues and statutory losses, plus consensus price target range, are summarized.
